RWM
EW icon

Rialto Wealth Management’s Edwards Lifesciences EW Stock Holding History

Rialto Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42K Buy
71
+21
+42% +$1.76K ﹤0.01% 660
2026
Q1 		$4K Buy
50
+22
+79% +$1.81K ﹤0.01% 640
2025
Q4 		$2.39K Buy
28
+1
+4% +$82 ﹤0.01% 685
2025
Q3 		$2.1K Buy
27
+4
+17% +$313 ﹤0.01% 651
2025
Q2 		$1.8K Buy
+23
New +$1.72K ﹤0.01% 642

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Rialto Wealth Management's EW Position: Q2 2026 in Review

Rialto Wealth Management increased its Edwards Lifesciences (EW) stake by 42% in Q2 2026, buying an estimated $1.76K and bringing the position to 71 shares worth $6.42K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Rialto Wealth Management first reported a position in EW in Q2 2025 and has held it in 5 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Rialto Wealth Management held 71 shares of Edwards Lifesciences worth $6.42K as of Q2 2026.
  • Rialto Wealth Management bought 21 Edwards Lifesciences shares in Q2 2026, an estimated $1.76K.
  • Edwards Lifesciences made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #660 holding.
  • Rialto Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.